ToxStrategies, Inc., 9390 Research Blvd, Ste. 100, Austin, TX, 78759, USA.
ToxStrategies, Inc., 31 College Place, Ste. B118, Asheville, NC, 28801, USA.
Toxicology. 2020 Apr 30;436:152427. doi: 10.1016/j.tox.2020.152427. Epub 2020 Mar 4.
The hypothesis that in utero exposures to low levels of trichloroethylene (TCE) may increase the risk of congenital heart defects (CHDs) in offspring remains a subject of substantial controversy within the scientific community due primarily to the reliance on an inconsistent and unreproducible experimental study in rats. To build on previous assessments that have primarily focused on epidemiological and experimental animal studies in developing conclusions, the objective of the current study is to conduct a systematic evaluation of mechanistic data related to in utero exposures to TCE and the development of CHDs. The evidence base was heterogeneous; 79 mechanistic datasets were identified, characterizing endpoints which ranged from molecular to organismal responses in seven species, involving both in vivo and in vitro study designs in mammalian and non-mammalian models. Of these, 24 datasets were considered reliable following critical appraisal using a study quality tool that employs metrics specific to the study type. Subsequent synthesis and integration demonstrated that the available mechanistic data: 1) did not support the potential for CHD hazard in humans, 2) did not support the biological plausibility of a response in humans based on organization via a putative adverse outcome pathway for valvulo-septal cardiac defects, and 3) were not suitable for serving as candidate studies in risk assessment. Findings supportive of an association were generally limited to in ovo chicken studies, in which TCE was administered in high concentration solutions via direct injection. Results of these in ovo studies were difficult to interpret for human health risk assessment given the lack of generalizability of the study models (including dose relevance, species-specific biological differences, variations in the construct of the study design, etc.). When the mechanistic data are integrated with findings from previous evaluations of human and animal evidence streams, the totality of evidence does not support CHDs as a critical effect in TCE human health risk assessment.
在子宫内暴露于低水平的三氯乙烯(TCE)可能会增加后代先天性心脏病(CHD)的风险这一假说,在科学界仍然存在很大争议,主要原因是依赖于在大鼠中进行的一项不一致且不可重复的实验研究。为了在前瞻性评估的基础上进一步研究,这些评估主要集中在发展中国家的流行病学和实验动物研究上,以得出结论,目前的研究旨在对与 TCE 宫内暴露和 CHD 发育相关的机制数据进行系统评估。证据基础存在异质性;确定了 79 个机制数据集,这些数据集描述了从分子到七个物种的机体反应的终点,涉及哺乳动物和非哺乳动物模型中的体内和体外研究设计。其中,使用特定于研究类型的指标对研究质量工具进行严格评估后,认为 24 个数据集是可靠的。随后的综合和整合表明,现有机制数据:1)不支持人类 CHD 危害的潜力,2)不支持基于假定的不良结局途径对瓣膜-间隔心脏缺陷的人体反应的生物学合理性,3)不适合作为风险评估中的候选研究。支持关联的发现通常仅限于胚胎鸡研究,其中 TCE 通过直接注射以高浓度溶液给药。由于研究模型的普遍性(包括剂量相关性、物种特异性生物学差异、研究设计结构的变化等),这些胚胎鸡研究的结果难以用于人类健康风险评估。当将机制数据与人类和动物证据流的先前评估结果结合起来时,总体证据不支持 CHD 作为 TCE 人类健康风险评估中的关键效应。